822 related articles for article (PubMed ID: 19284179)
1. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?
Cuellar NG; Ratcliffe SJ
Altern Ther Health Med; 2009; 15(2):22-8. PubMed ID: 19284179
[TBL] [Abstract][Full Text] [Related]
2. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
[TBL] [Abstract][Full Text] [Related]
3. Restless legs syndrome in end-stage renal disease.
Gigli GL; Adorati M; Dolso P; Piani A; Valente M; Brotini S; Budai R
Sleep Med; 2004 May; 5(3):309-15. PubMed ID: 15165541
[TBL] [Abstract][Full Text] [Related]
4. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
Ferini-Strambi L; Aarskog D; Partinen M; Chaudhuri KR; Sohr M; Verri D; Albrecht S
Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497
[TBL] [Abstract][Full Text] [Related]
5. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
[TBL] [Abstract][Full Text] [Related]
6. Outcome of restless legs severity after continuous positive air pressure (CPAP) treatment in patients affected by the association of RLS and obstructive sleep apneas.
Delgado Rodrigues RN; Alvim de Abreu E Silva Rodrigues AA; Pratesi R; Krieger J
Sleep Med; 2006 Apr; 7(3):235-9. PubMed ID: 16564217
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
[TBL] [Abstract][Full Text] [Related]
9. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
Fulda S; Wetter TC
Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
[TBL] [Abstract][Full Text] [Related]
10. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
Kallweit U; Siccoli MM; Poryazova R; Werth E; Bassetti CL
Eur Neurol; 2009; 62(3):176-9. PubMed ID: 19602890
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
Giorgi L; Ritchie SY; Kirsch JM
Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
[TBL] [Abstract][Full Text] [Related]
12. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
[TBL] [Abstract][Full Text] [Related]
13. Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep).
Allen RP; Kosinski M; Hill-Zabala CE; Calloway MO
Sleep Med; 2009 May; 10(5):531-9. PubMed ID: 18805054
[TBL] [Abstract][Full Text] [Related]
14. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study.
Wang J; O'Reilly B; Venkataraman R; Mysliwiec V; Mysliwiec A
Sleep Med; 2009 Oct; 10(9):973-5. PubMed ID: 19230757
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
Allen RP; Ritchie SY
Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
[TBL] [Abstract][Full Text] [Related]
17. Bupropion and restless legs syndrome: a randomized controlled trial.
Bayard M; Bailey B; Acharya D; Ambreen F; Duggal S; Kaur T; Rahman ZU; Roller K; Tudiver F
J Am Board Fam Med; 2011; 24(4):422-8. PubMed ID: 21737767
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
[TBL] [Abstract][Full Text] [Related]
19. Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study).
Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2008 Jul; 9(5):537-41. PubMed ID: 18276187
[TBL] [Abstract][Full Text] [Related]
20. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]